HFS
IRMD icon

Hantz Financial Services’s iRadimed IRMD Stock Holding History

Hantz Financial Services’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-70
Closed -$2K – 1106
2022
Q2 		$2K Hold
70
– – ﹤0.01% 935
2022
Q1 		$3K Buy
+70
New +$3.24K ﹤0.01% 931

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Hantz Financial Services's IRMD Position: Q3 2022 in Review

Hantz Financial Services sold out of iRadimed (IRMD) in Q3 2022, closing a stake of 70 shares — an estimated $2K sold.

Hantz Financial Services first reported a position in IRMD in Q1 2022 and held it in 2 quarters. The position peaked at $3K in Q1 2022. 86 funds tracked by Wall St. Rank hold IRMD as of Q3 2022.

  • Hantz Financial Services reported no remaining iRadimed position as of Q3 2022 after selling out during the quarter.
  • Hantz Financial Services sold 70 iRadimed shares in Q3 2022, an estimated $2K.
  • Hantz Financial Services first reported a position in iRadimed in Q1 2022 and held it in 2 quarters.
  • Hantz Financial Services's iRadimed position peaked at $3K in Q1 2022.
  • 86 funds tracked by Wall St. Rank held iRadimed as of Q3 2022.

Based on Hantz Financial Services's 13F filing for Q3 2022, filed 15 Nov 2022.